CLARIVATE PLC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CLARIVATE PLC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $255.01M | Mar 2, 2020 |
| FY2019 | Sep 30, 2019 | $243.00M | Mar 2, 2020 |
| FY2019 | Jun 30, 2019 | $242.31M | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | $234.03M | Mar 2, 2020 |
| FY2019 | Dec 31, 2018 | $245.25M | Mar 2, 2020 |
| FY2019 | Sep 30, 2018 | $242.90M | Mar 2, 2020 |
| FY2019 | Jun 30, 2018 | $243.30M | Mar 2, 2020 |
| FY2019 | Mar 31, 2018 | $237.03M | Mar 2, 2020 |
| FY2019 | Dec 31, 2017 | $917.63M | Mar 2, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.46B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $2.56B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $2.63B | Feb 24, 2026 |
| FY2023 | Jun 30, 2023 | $668.80M | Aug 7, 2023 |
| FY2023 | Mar 31, 2023 | $629.10M | May 9, 2023 |
| FY2024 | Dec 31, 2022 | $2.66B | Feb 19, 2025 |
| FY2022 | Sep 30, 2022 | $635.70M | Nov 8, 2022 |
| FY2023 | Jun 30, 2022 | $686.60M | Aug 7, 2023 |
| FY2023 | Mar 31, 2022 | $662.20M | May 9, 2023 |
| FY2021 | Dec 31, 2021 | $560.70M | Mar 10, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($201.10M) | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | ($636.70M) | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | ($911.20M) | Feb 24, 2026 |
| FY2023 | Jun 30, 2023 | ($123.10M) | Aug 7, 2023 |
| FY2023 | Mar 31, 2023 | $43.50M | Aug 7, 2023 |
| FY2024 | Dec 31, 2022 | ($3.96B) | Feb 19, 2025 |
| FY2022 | Sep 30, 2022 | ($4.42B) | Nov 8, 2022 |
| FY2023 | Jun 30, 2022 | $62.40M | Aug 7, 2023 |
| FY2023 | Mar 31, 2022 | $69.50M | Aug 7, 2023 |
| FY2023 | Dec 31, 2021 | ($270.50M) | Feb 27, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $71.50M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | ($275.60M) | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | ($734.70M) | Feb 24, 2026 |
| FY2023 | Jun 30, 2023 | ($88.30M) | Aug 7, 2023 |
| FY2023 | Mar 31, 2023 | $54.60M | May 9, 2023 |
| FY2024 | Dec 31, 2022 | ($3.93B) | Feb 19, 2025 |
| FY2022 | Sep 30, 2022 | ($4.38B) | Nov 8, 2022 |
| FY2023 | Jun 30, 2022 | $86.20M | Aug 7, 2023 |
| FY2023 | Mar 31, 2022 | $44.90M | May 9, 2023 |
| FY2021 | Dec 31, 2021 | $31.93M | Mar 10, 2022 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $708.60M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $727.60M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $739.70M | Feb 24, 2026 |
| FY2023 | Jun 30, 2023 | $192.90M | Aug 7, 2023 |
| FY2023 | Mar 31, 2023 | $194.80M | May 9, 2023 |
| FY2024 | Dec 31, 2022 | $729.90M | Feb 19, 2025 |
| FY2022 | Sep 30, 2022 | $169.50M | Nov 8, 2022 |
| FY2023 | Jun 30, 2022 | $186.10M | Aug 7, 2023 |
| FY2023 | Mar 31, 2022 | $193.70M | May 9, 2023 |
| FY2023 | Dec 31, 2021 | $643.00M | Feb 27, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $628.50M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $646.60M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $744.20M | Feb 24, 2026 |
| FY2023 | Jun 30, 2023 | $389.90M | Aug 7, 2023 |
| FY2023 | Mar 31, 2023 | $227.50M | May 9, 2023 |
| FY2024 | Dec 31, 2022 | $509.30M | Feb 19, 2025 |
| FY2022 | Sep 30, 2022 | $372.40M | Nov 8, 2022 |
| FY2023 | Jun 30, 2022 | $164.60M | Aug 7, 2023 |
| FY2023 | Mar 31, 2022 | $67.40M | May 9, 2023 |
| FY2023 | Dec 31, 2021 | $323.80M | Feb 27, 2024 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $263.20M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $289.10M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $242.50M | Feb 24, 2026 |
| FY2023 | Jun 30, 2023 | $116.90M | Aug 7, 2023 |
| FY2023 | Mar 31, 2023 | $59.30M | May 9, 2023 |
| FY2024 | Dec 31, 2022 | $202.90M | Feb 19, 2025 |
| FY2022 | Sep 30, 2022 | $156.50M | Nov 8, 2022 |
| FY2023 | Jun 30, 2022 | $89.10M | Aug 7, 2023 |
| FY2023 | Mar 31, 2022 | $41.40M | May 9, 2023 |
| FY2023 | Dec 31, 2021 | $118.50M | Feb 27, 2024 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.07B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $11.49B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $12.71B | Feb 19, 2025 |
| FY2023 | Jun 30, 2023 | $13.71B | Aug 7, 2023 |
| FY2023 | Mar 31, 2023 | $13.94B | May 9, 2023 |
| FY2023 | Dec 31, 2022 | $13.94B | Feb 27, 2024 |
| FY2022 | Sep 30, 2022 | $13.75B | Nov 8, 2022 |
| FY2022 | Jun 30, 2022 | $18.84B | Aug 9, 2022 |
| FY2022 | Mar 31, 2022 | $19.74B | May 9, 2022 |
| FY2022 | Dec 31, 2021 | $20.18B | Oct 12, 2023 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.23B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $6.35B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $6.71B | Feb 19, 2025 |
| FY2023 | Jun 30, 2023 | $6.77B | Aug 7, 2023 |
| FY2023 | Mar 31, 2023 | $6.98B | May 9, 2023 |
| FY2023 | Dec 31, 2022 | $7.13B | Feb 27, 2024 |
| FY2022 | Sep 30, 2022 | $7.67B | Nov 8, 2022 |
| FY2022 | Jun 30, 2022 | $7.80B | Aug 9, 2022 |
| FY2022 | Mar 31, 2022 | $8.03B | May 9, 2022 |
| FY2022 | Dec 31, 2021 | $8.26B | Oct 12, 2023 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.84B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $5.14B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $5.99B | Feb 24, 2026 |
| FY2023 | Jun 30, 2023 | $6.94B | Aug 7, 2023 |
| FY2023 | Mar 31, 2023 | $6.96B | Aug 7, 2023 |
| FY2025 | Dec 31, 2022 | $6.81B | Feb 24, 2026 |
| FY2022 | Sep 30, 2022 | $6.07B | Nov 8, 2022 |
| FY2023 | Jun 30, 2022 | $11.04B | Aug 7, 2023 |
| FY2023 | Mar 31, 2022 | $11.71B | Aug 7, 2023 |
| FY2024 | Dec 31, 2021 | $11.93B | Feb 19, 2025 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.57B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $1.57B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $2.02B | Feb 24, 2026 |
| FY2023 | Jun 30, 2023 | $2.90B | Aug 7, 2023 |
| FY2023 | Mar 31, 2023 | $2.89B | May 9, 2023 |
| FY2024 | Dec 31, 2022 | $2.88B | Feb 19, 2025 |
| FY2022 | Sep 30, 2022 | $2.80B | Nov 8, 2022 |
| FY2022 | Jun 30, 2022 | $7.53B | Aug 9, 2022 |
| FY2022 | Mar 31, 2022 | $7.80B | May 9, 2022 |
| FY2023 | Dec 31, 2021 | $7.90B | Feb 27, 2024 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($7.51B) | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | ($7.31B) | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | ($6.65B) | Feb 19, 2025 |
| FY2023 | Jun 30, 2023 | ($5.78B) | Aug 7, 2023 |
| FY2023 | Mar 31, 2023 | ($5.63B) | May 9, 2023 |
| FY2023 | Dec 31, 2022 | ($5.66B) | Feb 27, 2024 |
| FY2022 | Sep 30, 2022 | ($5.96B) | Nov 8, 2022 |
| FY2022 | Jun 30, 2022 | ($1.52B) | Aug 9, 2022 |
| FY2022 | Mar 31, 2022 | ($1.55B) | May 9, 2022 |
| FY2022 | Dec 31, 2021 | ($1.60B) | Oct 12, 2023 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $329.20M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $295.20M | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $370.70M | Feb 19, 2025 |
| FY2023 | Jun 30, 2023 | $436.10M | Aug 7, 2023 |
| FY2023 | Mar 31, 2023 | $364.20M | May 9, 2023 |
| FY2023 | Dec 31, 2022 | $356.80M | Feb 27, 2024 |
| FY2022 | Sep 30, 2022 | $446.00M | Nov 8, 2022 |
| FY2022 | Jun 30, 2022 | $359.70M | Aug 9, 2022 |
| FY2022 | Mar 31, 2022 | $500.20M | May 9, 2022 |
| FY2022 | Dec 31, 2021 | $430.90M | Oct 12, 2023 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $3.49B | Feb 3, 2022 |
| FY2019 | Dec 31, 2019 | $1.64B | Mar 2, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 24, 2026 |
| FY2023 | Jun 30, 2023 | 0 | Aug 7, 2023 |
| FY2023 | Mar 31, 2023 | 0 | May 9, 2023 |
| FY2024 | Dec 31, 2022 | (5) | Feb 19, 2025 |
| FY2022 | Sep 30, 2022 | (6) | Nov 8, 2022 |
| FY2023 | Jun 30, 2022 | 0 | Aug 7, 2023 |
| FY2023 | Mar 31, 2022 | 0 | May 9, 2023 |
| FY2021 | Dec 31, 2021 | 0 | Mar 10, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 24, 2026 |
| FY2023 | Jun 30, 2023 | 0 | Aug 7, 2023 |
| FY2023 | Mar 31, 2023 | 0 | May 9, 2023 |
| FY2024 | Dec 31, 2022 | (6) | Feb 19, 2025 |
| FY2022 | Sep 30, 2022 | (6) | Nov 8, 2022 |
| FY2023 | Jun 30, 2022 | 0 | Aug 7, 2023 |
| FY2023 | Mar 31, 2022 | 0 | May 9, 2023 |
| FY2021 | Dec 31, 2021 | 0 | Mar 10, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 640.70M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 691.40M | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | 666.10M | Feb 19, 2025 |
| FY2023 | Jun 30, 2023 | 676.10M | Aug 7, 2023 |
| FY2023 | Mar 31, 2023 | 675.60M | May 9, 2023 |
| FY2023 | Dec 31, 2022 | 674.40M | Feb 27, 2024 |
| FY2022 | Sep 30, 2022 | 673.80M | Nov 8, 2022 |
| FY2022 | Jun 30, 2022 | 673.32M | Aug 9, 2022 |
| FY2022 | Mar 31, 2022 | 678.97M | May 9, 2022 |
| FY2022 | Dec 31, 2021 | 683.14M | Oct 12, 2023 |